| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2024-06-04 | OssDsign | OssDsign AB: OssDsign publicerar Årsredovisning 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-06-04 | OssDsign | OssDsign AB: OssDsign publishes Annual Report 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
Pressreleaser |
OssDsign AB: OssDsign publishes Annual Report 2023”We enter 2024 as a pure play orthobiologics company with full focus on the U.S. market, fortified with excellent clinical results and an expanded indication for OssDsign Catalyst®” said Morten Henneveld, CEO, OssDsign AB. |
||||
| 2024-05-30 | OssDsign | OssDsign AB: 5,000 patients treated with OssDsign Catalyst® in the U.S. | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-30 | OssDsign | OssDsign AB: 5 000 patienter behandlade med OssDsign Catalyst® i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-24 | OssDsign | OssDsign AB: NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN OSSDSIGN AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-24 | OssDsign | OssDsign AB: KALLELSE TILL ÅRSSTÄMMA I OSSDSIGN AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-16 | OssDsign | OssDsign AB: Change of financial calendar | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-16 | OssDsign | OssDsign AB: Ändring av finansiell kalender | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Redeye | Redeye: OssDsign Q1 - An accelerating turnaround | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: A new beginning – Q1 review | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-05-14 | OssDsign | OssDsign AB (publ) publishes Q1 2024 interim report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-14 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för första kvartalet 2024 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-29 | OssDsign | OssDsign AB: OssDsign får tillgång till 100 nya sjukhus inom U.S. Veteran Affairs med sitt syntetiska bengraft | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-29 | OssDsign | OssDsign AB: OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-11 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Another quarter of triple-digit Catalyst growth expected | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-04-02 | OssDsign | OssDsign AB: OssDsign awarded long-term agreement with Premier, Inc. | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-02 | OssDsign | OssDsign AB: OssDsign tecknar flerårigt avtal med Premier, Inc. | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-07 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Update after HC seminar and news in the spinal fusion market | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-29 | OssDsign | OssDsign AB: OssDsign utser Tom Buckland till Chief Technical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-29 | OssDsign | OssDsign AB: OssDsign appoints Tom Buckland as Chief Technical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-07 | Redeye | Redeye: Q4 - Sales will go up, and costs will go down | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-07 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Restructuring completed, focus on 2024 | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-06 | OssDsign | OssDsign AB (publ) publishes year-end report 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-06 | OssDsign | OssDsign AB (publ) publicerar bokslutskommuniké 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-29 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Right time to fuse the spine | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-01-24 | OssDsign | OssDsign AB: 12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-24 | OssDsign | OssDsign AB: Tolvmånadersdata från klinisk studie med OssDsign Catalyst™ publicerad i Biomedical Journal of Scientific & Technical Research | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-09 | OssDsign | OssDsign AB: OssDsign reports exceptional data from the clinical study TOP FUSION | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-09 | OssDsign | OssDsign AB: OssDsign rapporterar exceptionella data från den kliniska studien TOP FUSION | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-07 | Redeye | Redeye: OssDsign - Higher-than-expected Q4 preliminary sales | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-06 | OssDsign | OssDsign AB: OssDsign's revenues for the fourth quarter of 2023 are expected to exceed market estimates | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-06 | OssDsign | OssDsign AB: OssDsigns intäkter för det fjärde kvartalet 2023 förväntas överstiga marknadens förväntningar | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: SEB Venture Capital has sold its holding in OssDsign | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: SEB Venture Capital har avyttrat sitt innehav i OssDsign | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: OssDsign byter Certified Adviser till Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: OssDsign changes Certified Adviser to Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-23 | Penser Access | Penser Access: Intervju med OssDsign - Erik Penser Bank - 23 november 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-22 | Penser Access | Penser Access: Benhård tillväxt - OssDsign | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-22 | Redeye | Redeye: OssDsign Q3 - Catalyst is growing as expected | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-21 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för tredje kvartalet 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-21 | OssDsign | OssDsign AB (publ) publishes Q3 2023 Interim Report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-16 | OssDsign | Extra bolagsstämma har hållits i OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-16 | OssDsign | Extraordinary General Meeting held in OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-11 | OssDsign | OssDsign AB: OssDsign Catalyst blir allmänt tillgänglig för alla militära vårdinrättningar i USA via ECAT | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-09 | Penser Access | Penser Access: Intervju med OssDsign - Erik Penser Bank - 9 oktober 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-28 | Redeye | Redeye: OssDsign - Fully funded and fully focused | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-28 | Penser Access | Penser Access: Strategiskifte och nyemission - OssDsign | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-27 | OssDsign | Notice to attend the extraordinary general meeting in OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-27 | OssDsign | Kallelse till extra bolagsstämma i OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign has carried out a directed share issue of approximately SEK 150 million | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign har genomfört en riktad nyemission av aktier om cirka 150 miljoner kronor | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign explores the conditions to carry out a directed share issue | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign utreder förutsättningarna att genomföra en riktad nyemission av aktier | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign announces strategic shift to become a pure play orthobiologics company | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign genomför strategiskifte för att bli ett renodlat ortobiologiföretag | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-18 | OssDsign | OssDsign AB: OssDsign® Catalyst får utökat marknadsgodkännande från FDA för betydande ny indikation för användning i ryggradsburar | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-13 | OssDsign | OssDsign AB: 2 000 patienter behandlade med OssDsign[®] Catalyst i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-30 | Penser Access | Penser Access: Intervju med OssDsign - Erik Penser Bank - 29 augusti 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-24 | Redeye | Redeye: OssDsign - Catalyst sets up for a turnaround | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-23 | Penser Access | Penser Access: 148% tillväxt i USA - OssDsign | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-22 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för andra kvartalet 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-22 | OssDsign | OssDsign AB (publ) publishes Q2 2023 Interim Report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-16 | OssDsign | OssDsign AB: OssDsign har passerat 200 patienter i sitt prospektiva multicenterregister för ryggradsfusion, PROPEL | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||